Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term therapy. Found 483 abstracts

no pagination
Held-Warmkessel J. How to care for men with prostate cancer. Nursing. 1999 Nov;29(11):51-3.
Herold DM, Hanlon AL, Hanks GE. Diabetes mellitus: A predictor for late radiation morbidity. International Journal of Radiation Oncology Biology Physics. 1999 Feb;43(3):475-9.
Levy MH. NCCN task force report: Supportive and palliative care. Oncology-New York. 1999 Nov;13(11A):517-22.
Miller SM, Fang CY, Manne SL, Engstrom PF, Daly MB. Decision making about prophylactic oophorectomy among at-risk women: Psychological influences and implications. Gynecologic Oncology. 1999 Dec;75(3):406-12.
Weiner LM. Paclitaxel in the treatment of esophageal cancer. Seminars in Oncology. 1999 Feb;26(1):106-8.
Wiseman GA, White CA, Witzig TE, Gordon LI, Emmanouilides C, Raubitschek A, Janakiraman N, Gutheil J, Schilder RJ, Spies S, Silverman DH, Grillo-Lopez AJ. Radioimmunotherapy of relapsed non-Hodgkin's lymphoma with Zevalin, a Y-90-labeled anti-CD20 monoclonal antibody. Clinical Cancer Research. 1999 Oct;5(10):3281S-3286S.
Witzig TE, White CA, Wiseman GA, Gordon LI, Emmanouilides C, Raubitschek A, Janakiraman N, Gutheil J, Schilder RJ, Spies S, Silverman DH, Parker E, Grillo-Lopez AJ. Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsed or refractory CD20(+) B-cell non-Hodgkin's lymphoma. Journal of Clinical Oncology. 1999 Dec;17(12):3793-803.
Algan O, Fowble B, McNeeley S, Fein D. Use of the prone position in radiation treatment for women with early stage breast cancer. International Journal of Radiation Oncology Biology Physics. 1998 Mar 15;40(5):1137-40.
Anderson PR, Hanlon AL, Patchefsky A, Al-Saleem T, Hanks GE. Perineural invasion and Gleason 7-10 tumors predict increased failure in prostate cancer patients with pretreatment PSA < 10 ng/ml treated with conformal external beam radiation therapy. International Journal of Radiation Oncology Biology Physics. 1998 Jul 15;41(5):1087-92.
Bookman MA. Biological therapy for gynecologic malignancies. Cancer Treat Res. 1998 Jan;95:115-47.
Chapman JD, Engelhardt EL, Stobbe CC, Schneider RF, Gerald GE. Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays. Radiotherapy and Oncology. 1998 Mar;46(3):229-37.
Das IJ, Cheng EC, Freedman G, Fowble B. Lung and heart dose volume analyses with CT simulator in radiation treatment of breast cancer. International Journal of Radiation Oncology Biology Physics. 1998 Aug;42(1):11-9.
Dresler CM. Kidney metastases. Chest Surg Clin N Am. 1998 Feb;8(1):127-9.
Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. Journal of the National Cancer Institute. 1998 Sep 16;90(18):1371-88.
Freedman GM, Fowble BL, Hanlon AL, Myint MA, Hoffman JP, Sigurdson ER, Eisenberg BL, Goldstein LJ, Fein DA. A close or positive margin after mastectomy is not an indication for chest wall irradiation except in women aged fifty or younger. International Journal of Radiation Oncology Biology Physics. 1998 Jun;41(3):599-605.
Green GA, Hanlon AL, Al-Saleem T, Hanks GE. A Gleason score of 7 predicts a worse outcome for prostate carcinoma patients treated with radiotherapy. Cancer. 1998 Sep;83(5):971-6.
Hanlon AL, Moore DF, Hanks GE. Modeling postradiation prostate specific antigen level kinetics - Predictors of rising postnadir slope suggest cure in men who remain biochemically free of prostate carcinoma. Cancer. 1998 Jul;83(1):130-4.
Hoffman JP, Cooper HS, Young NA, Pendurthi TK. Preoperative chemotherapy of chemoradiotherapy for the treatment of adenocarcinoma of the pancreas and ampulla of Vater. J Hepatobiliary Pancreat Surg. 1998 Jan;5(3):251-4.
Hoffman JP, Pendurthi TK, Johnson DE. Management of exocrine carcinoma of the pancreas. Cancer Treat Res. 1998 Jan;98:65-82.
Houghton A, Coit D, Bloomer W, Buzaid A, Chu D, Eisenberg B, Guitart J, Johnson T, Miller S, Sener S, Tanabe K, Thompson J, Urist M, Walker M. NCCN Melanoma Practice Guidelines. Oncology-New York. 1998 Jul;12(7A):153-77.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term therapy

therapy Human cancer radiation antigen radiotherapy adenocarcinoma surgery randomized trial Adenocarcinoma diagnosis breast cancer Preoperative Care Adjuvant Chemotherapy complications prostate cancer malignant-melanoma prostate carcinoma i-131 methods tumor mastectomy radiation- Prognosis Pancreatic Neoplasms progression therapeutic use Adjuvant Radiotherapy carcinoma margins trial marrow transplantation f-18 Combined Modality Therapy insitu Adoptive Transfer positron emission tomography lumpectomy multivariate-analysis Male term follow-up psychology risk Neoadjuvant Therapy Renal Cell Carcinoma treatment techniques Common Bile Duct Neoplasms Female anti-cd20 monoclonal-antibody bioreducible markers Antineoplastic Agents Ovarian Neoplasms tumor hypoxia information dose-escalation diabetes distress iodoazomycin arabinoside Mass Screening Lung Neoplasms susceptibility tomography kinetics 3DCRT Gleason score nursing specific antigen cells-invitro modified radical-mastectomy prophylactic oophorectomy stage-i Middle Age evidence PET radiation therapy dtpa morbidity randomized clinical-trial treatment position serum uterine cervix plasma-lipids prognostic factors prostate-cancer 4 mm hormone replacement pathology computed- cutaneous melanoma imaging breast-cancer risk perineural invasion young women Vater's Ampulla cardiac effect lymph-node dissection prone b-cell lymphoma lung volume Prostatic Neoplasms chemotherapy Growth Substances prostate specific antigen carcinoembryonic antigen Patient Discharge blunting etiology Prospective Studies postmenopausal women serotherapy receptor-positive tumors lymphadenectomy serum-lipoproteins physiopathology ll2 patient radical prostatectomy cytokinetics clinical stage rat mammary-carcinoma breast-cancer patients Kidney Neoplasms recurrence Perioperative Care multicenter Patient Education Genetic Engineering Bispecific Antibodies Gleason grade Interferons breast follow-up style Case Report Postoperative Care fields premenopausal women relapse pulmonary-function randomized Cytokines prostate familial ovarian-cancer oral-contraceptive use physiology oxygenation heart volume Risk Factors Immunotherapy fluoromisonidazole
Last updated on Wednesday, March 04, 2020